Jennifer A. Doherty

31.9k total citations · 3 hit papers
109 papers, 6.0k citations indexed

About

Jennifer A. Doherty is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jennifer A. Doherty has authored 109 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 27 papers in Oncology and 27 papers in Genetics. Recurrent topics in Jennifer A. Doherty's work include Ovarian cancer diagnosis and treatment (24 papers), Endometrial and Cervical Cancer Treatments (22 papers) and Estrogen and related hormone effects (14 papers). Jennifer A. Doherty is often cited by papers focused on Ovarian cancer diagnosis and treatment (24 papers), Endometrial and Cervical Cancer Treatments (22 papers) and Estrogen and related hormone effects (14 papers). Jennifer A. Doherty collaborates with scholars based in United States, United Kingdom and South Africa. Jennifer A. Doherty's co-authors include Doris M. Kupfer, Maureen F. Zakowski, Richard K. Wilson, Mark G. Kris, Elaine R. Mardis, Katerina Politi, Robert T. Heelan, Valerie W. Rusch, Vincent A. Miller and Lucinda A. Fulton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Oncology.

In The Last Decade

Jennifer A. Doherty

105 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib

2004 3.5k citations Jennifer A. Doherty et al. profile →
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage

2018 345 citations Lauren C. Peres, Holly R. Harris et al. JNCI Journal of the National Cancer Institute profile →
Endometriosis Typology and Ovarian Cancer Risk

2024 57 citations Mollie E. Barnard, Leslie V. Farland et al. JAMA profile →

Peers

Jennifer A. Doherty

ONCOL

PRM

Bernard Têtu Canada

Siqing Fu United States

Francesco Perrone Italy

Peter A. van Dam Belgium

Helena Earl United Kingdom

Francesco Boccardo Italy

T. Tong United States

Achim Rody Germany

Philip C. Prorok United States

Jennifer J. Wheler United States

Bernard Têtu Canada

Jennifer A. Doherty

2.7k ×0.9

ONCOL

2.3k ×0.8

PRM

2.6k ×1.3

1.5k ×1.2

560 ×0.7

Citations per year, relative to Jennifer A. Doherty Jennifer A. Doherty (= 1×) peers Bernard Têtu

Countries citing papers authored by Jennifer A. Doherty

Since Specialization

Citations

This map shows the geographic impact of Jennifer A. Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer A. Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer A. Doherty more than expected).

Fields of papers citing papers by Jennifer A. Doherty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer A. Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer A. Doherty. The network helps show where Jennifer A. Doherty may publish in the future.

Co-authorship network of co-authors of Jennifer A. Doherty

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer A. Doherty. A scholar is included among the top collaborators of Jennifer A. Doherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer A. Doherty. Jennifer A. Doherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Townsend, Mary K., Allison F. Vitonis, Holly R. Harris, et al.. (2025). Associations between Parity, History of Breastfeeding, and T-cell Profile of Ovarian Tumors. Cancer Epidemiology Biomarkers & Prevention. 34(4). 550–559.

Davidson, Natalie R., Mollie E. Barnard, Amy Campbell, et al.. (2024). Molecular Subtypes of High-Grade Serous Ovarian Cancer across Racial Groups and Gene Expression Platforms. Cancer Epidemiology Biomarkers & Prevention. 33(8). 1114–1125. 4 indexed citations

Barnard, Mollie E., Leslie V. Farland, Bin Yan, et al.. (2024). Endometriosis Typology and Ovarian Cancer Risk. JAMA. 332(6). 482–482. 57 indexed citations breakdown →

Feng, Yue, Huining Kang, Kimberly K. Leslie, et al.. (2024). Early menopause and hormone therapy as determinants for lung health outcomes: a secondary analysis using the PLCO trial. Thorax. 79(10). 961–969. 2 indexed citations

Barnard, Mollie E., Leslie V. Farland, Bin Yan, et al.. (2024). Endometriosis Typology and Ovarian Cancer Risk. Obstetrical & Gynecological Survey. 79(12). 718–719. 1 indexed citations

McPherson, Jordan P., Magdalena Kovacsovics-Bankowski, Joanne Jeter, et al.. (2023). A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome. Frontiers in Immunology. 14. 1229823–1229823. 16 indexed citations

Danciu, Ioana, Hong‐Jun Yoon, Jamaludin Mohd‐Yusof, et al.. (2023). Deep learning uncertainty quantification for clinical text classification. Journal of Biomedical Informatics. 149. 104576–104576. 3 indexed citations

Iyer, Hari S., Xun Shi, Iona Cheng, et al.. (2023). Advancing Social and Environmental Research in Cancer Registries Using Geomasking for Address-Level Data. Cancer Epidemiology Biomarkers & Prevention. 32(11). 1485–1489. 3 indexed citations

Ibiebele, Torukiri I, Jennifer A. Doherty, Holly R. Harris, et al.. (2023). Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium. Cancer Epidemiology Biomarkers & Prevention. 32(8). 1087–1096. 5 indexed citations

10.

Dood, Robert, et al.. (2022). Mortality Patterns of Synchronous Uterine and Ovarian Cancers: A SEER Registry Analysis. Cancer Epidemiology Biomarkers & Prevention. 31(11). 2038–2045. 1 indexed citations

11.

Weber, Lukas M., Peter F. Hickey, Kristofer C. Berrett, et al.. (2021). Genetic demultiplexing of pooled single-cell RNA-sequencing samples in cancer facilitates effective experimental design. GigaScience. 10(9). 21 indexed citations

12.

Palmer, Ellen L., John Higgins, Saeed Hassanpour, et al.. (2019). Assessing data availability and quality within an electronic health record system through external validation against an external clinical data source. BMC Medical Informatics and Decision Making. 19(1). 143–143. 6 indexed citations

13.

Palmer, Ellen L., Saeed Hassanpour, John Higgins, Jennifer A. Doherty, & Tracy Onega. (2019). Building a tobacco user registry by extracting multiple smoking behaviors from clinical notes. BMC Medical Informatics and Decision Making. 19(1). 141–141. 15 indexed citations

14.

Doherty, Jennifer A., Allan Jensen, Linda E Kelemen, et al.. (2017). Improvement in 5-Year Survival Rates for the Most Common Types of Cancer, 1975-2012. JNCI Journal of the National Cancer Institute. 109(5). 23 indexed citations

15.

Way, Gregory P., Chen Wang, Habib Hamidi, et al.. (2016). Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes. G3 Genes Genomes Genetics. 6(12). 4097–4103. 26 indexed citations

16.

Gossai, Anala, Tim Waterboer, Heather H. Nelson, et al.. (2016). Prospective Study of Human Polyomaviruses and Risk of Cutaneous Squamous Cell Carcinoma in the United States. Cancer Epidemiology Biomarkers & Prevention. 25(5). 736–744. 5 indexed citations

17.

Pearce, Celeste Leigh, Daniel O. Stram, Roberta B. Ness, et al.. (2015). Population Distribution of Lifetime Risk of Ovarian Cancer in the United States. Cancer Epidemiology Biomarkers & Prevention. 24(4). 671–676. 71 indexed citations

18.

Chen, Chu, Jennifer A. Doherty, & Noel S. Weiss. (2006). Polymorphisms in CYP17 and CYP19, unopposed estrogen use, body mass index, full-term pregnancy, and endometrial cancer risk.. Cancer Research. 66. 1269–1269. 1 indexed citations

19.

Weiss, Jocelyn M., Babette S. Saltzman, Jennifer A. Doherty, et al.. (2006). Risk Factors for the Incidence of Endometrial Cancer according to the Aggressiveness of Disease. American Journal of Epidemiology. 164(1). 56–62. 33 indexed citations

20.

Saltzman, Babette S., Jennifer A. Doherty, Deirdre A. Hill, et al.. (2006). Diabetes and endometrial cancer: An evaluation of the modifying effects of other known risk factors.. Cancer Epidemiology and Prevention Biomarkers. 15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact